Treating Addiction With Psychedelics: An Interview With Professor David Nutt and Anthony Tennyson, Awakn Life Sciences



July 16, 2021

Psychedelics are being explored for a myriad of neurological and psychiatric conditions. In this video, Technology Networks speak with Professor David Nutt and Anthony Tennyson from Awakn Life Sciences, a Toronto-based company who focus on the use of psychedelics to treat addiction. We discussed the unique considerations of treating addiction, the role of psychotherapy in psychedelic treatments and how regulation of psychedelics could change in the near future.

BiopharmaDrug DiscoveryNeuroscience

Keep up to date with all your favourite videos and channels.

Get personalised notifications on new releases and channel content by subscribing to the LabTube eNewsletter.